Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts BioLineRx Ltd.

Equities

BLRX

IL0011015182

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:13 2024-06-10 am EDT 		5-day change 1st Jan Change
17.2 ILa +0.58% Intraday chart for BioLineRx Ltd. -6.01% -54.97%
May. 30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
May. 28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
Transcript : BioLineRx Ltd., Q4 2023 Earnings Call, Mar 26, 2024
Transcript : BioLineRx Ltd., Q3 2023 Earnings Call, Nov 20, 2023
Transcript : BioLineRx Ltd. - Special Call
Transcript : BioLineRx Ltd., Q2 2023 Earnings Call, Aug 30, 2023
Transcript : BioLineRx Ltd., Q2 2022 Earnings Call, Aug 16, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. News BioLineRx Ltd.
  5. Transcripts